Recent advances in understanding viral evasion of type I interferon

Immunology

Volumn 138, Issue 3, 2013, Pages 190-197

  Taylor, Kathryne E ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antiviral; Evasion; Inhibition; Interferon; Virus

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3; INTERFERON STIMULATED GENE FACTOR 3; JANUS KINASE; PROTEIN C JUN; RETINOIC ACID INDUCIBLE PROTEIN I; RNA POLYMERASE II; STAT PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

ANTIVIRAL ACTIVITY; CYTOKINE PRODUCTION; DENDRITIC CELL; EPIGENETICS; GENE DISRUPTION; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; NONHUMAN; ONCOGENE C JUN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; ROTAVIRUS INFECTION; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

ANIMALS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VIRUS DISEASES; VIRUSES;

EID: 84873304007     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12038     Document Type: Review

References (100)

1. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998; 95:15623-8.
2. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001; 69:912-20.
3. Donnelly RP, Kotenko SV. Interferon-λ: a new addition to an old family. J Interferon Cytokine Res 2010; 30:555-64.
4. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
5. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-50.
6. Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, Li K, Lemon SM. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog 2011; 7:e1002169.
7. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 2011; 85:8811-8.
8. Ahmad H, Gubbels R, Ehlers E, Meyer F, Waterbury T, Lin R, Zhang L. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing β-interferon (TRIF). J Biol Chem 2011; 286:7865-72.
9. Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol 2011; 55:762-9.
10. Maelfait J, Beyaert R. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev 2012; 76:33-45.
11. Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE Jr, Santangelo PJ. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 2012; 86:8245-58.
12. Solis M, Nakhaei P, Jalalirad M et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011; 85:1224-36.
13. Childs K, Randall R, Goodbourn S. Paramyxovirus V proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol 2012; 86:3411-21.
14. Yoneyama M, Kikuchi M, Natsukawa T et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-7.
15. van Kasteren PB, Beugeling C, Ninaber DK, Frias-Staheli N, van Boheemen S, Garcia-Sastre A, Snijder EJ, Kikkert M. Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 2012; 86:773-85.
16. Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K, Ou JH, Jung JU. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J Virol 2011; 85:10899-904.
17. Sun L, Xing Y, Chen X et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS ONE 2012; 7:e30802.
18. Wang D, Fang L, Li P et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 2011; 85:3758-66.
19. Gack MU, Shin YC, Joo CH et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446:916-20.
20. Varga ZT, Grant A, Manicassamy B, Palese P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing the mitochondrial membrane potential. J Virol 2012;86:8359-66.
21. Koshiba T, Yasukawa K, Yanagi Y, Kawabata S. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal 2011; 4:ra7.
22. Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011; 7:e1001311.
23. Kumar M, Jung SY, Hodgson AJ, Madden CR, Qin J, Slagle BL. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of β interferon. J Virol 2011; 85:987-95.
24. Nakhaei P, Hiscott J, Lin R. STING-ing the antiviral pathway. J Mol Cell Biol 2010; 2:110-2.
25. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 2012; 8:e1002780.
26. Yao XD, Rosenthal KL. Herpes simplex virus type 2 virion host shutoff protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial cells. J Gen Virol 2011;92(Pt 9):1981-93.
27. Eksioglu EA, Zhu H, Bayouth L, Bess J, Liu HY, Nelson DR, Liu C. Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells. PLoS ONE 2011; 6:e21186.
28. Tamura R, Kanda T, Imazeki F et al. Hepatitis C virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis 2011; 204:793-801.
29. Miorin L, Albornoz A, Baba MM, D'Agaro P, Marcello A. Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling. Virus Res 2012; 163:660-6.
30. Espada-Murao LA, Morita K. Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells. J Virol 2011; 85:6736-49.
31. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3'-5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 2011; 108:2396-401.
32. Boonyaratanakornkit J, Bartlett E, Schomacker H et al. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol 2011; 85:1495-506.
33. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol Cell 1998; 1:507-18.
34. Pfeffer LM. The role of nuclear factor κB in the interferon response. J Interferon Cytokine Res 2011; 31:553-9.
35. Schuhmann KM, Pfaller CK, Conzelmann KK. The measles virus V protein binds to p65 (RelA) to suppress NF-κB activity. J Virol 2011; 85:3162-71.
36. Gautheron J, Courtois G. "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-κB activation. Cell Mol Life Sci 2010; 67:3101-13.
37. Wang D, Fang L, Li K et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol 2012; 86:9311-22.
38. Ford E, Thanos D. The transcriptional code of human IFN-β gene expression. Biochim Biophys Acta 2010; 1799:328-36.
39. Halfmann P, Neumann G, Kawaoka Y. The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase. J Infect Dis 2011; 204(Suppl. 3):S953-6.
40. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008; 26:535-84.
41. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, Smiley JR. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001; 75:750-8.
42. Guo J, Peters KL, Sen GC. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 2000; 267:209-19.
43. Ye J, Maniatis T. Negative regulation of interferon-β gene expression during acute and persistent virus infections. PLoS ONE 2011; 6:e20681.
44. Vandevenne P, Lebrun M, El Mjiyad N et al. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS ONE 2011; 6:e16870.
45. Zhu H, Zheng C, Xing J, Wang S, Li S, Lin R, Mossman KL. Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J Virol 2011; 85:11079-89.
46. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 2009; 83:10395-405.
47. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008; 373:85-97.
48. Harman AN, Lai J, Turville S et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 2011; 118:298-308.
49. Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M Jr. Vpu mediates IRF3 depletion during HIV infection by a lysosomal-dependent mechanism. J Virol 2012;86:8367-74.
50. Ren J, Liu T, Pang L, Li K, Garofalo RP, Casola A, Bao X. A novel mechanism for the inhibition of interferon regulatory factor-3-dependent gene expression by human respiratory syncytial virus NS1 protein. J Gen Virol 2011; 92(Pt 9):2153-9.
51. Wang G, Chen G, Zheng D, Cheng G, Tang H. PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway. PLoS ONE 2011; 6:e17192.
52. Qu B, Qi X, Wu X et al. Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol 2012;86:8388-401.
53. Ma Y, Jin H, Valyi-Nagy T, Cao Y, Yan Z, He B. Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection. J Virol 2012; 86:2188-96.
54. Matthys V, Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction. J Virol 2011; 85:4752-60.
55. Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez-Sobrido L, de la Torre JC, Kunz S. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol 2012; 86:7728-38.
56. Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε. Cell Res 2011; 21:793-806.
57. Unterholzner L, Sumner RP, Baran M et al. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 2011; 7:e1002247.
58. Ning S, Pagano JS, Barber GN. IRF7: activation, regulation, modification and function. Genes Immun 2011; 12:399-414.
59. Liang Q, Fu B, Wu F, Li X, Yuan Y, Zhu F. ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of IRF7 by IKKε and TBK1 as an alternative substrate. J Virol 2012;86:10162-72.
60. Sathish N, Zhu FX, Golub EE, Liang Q, Yuan Y. Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. J Biol Chem 2011; 286:746-56.
61. Kitagawa Y, Yamaguchi M, Zhou M et al. A tryptophan-rich motif in the human parainfluenza virus type 2 V protein is critical for the blockade of toll-like receptor 7 (TLR7)- and TLR9-dependent signaling. J Virol 2011; 85:4606-11.
62. Fiebach AR, Guzylack-Piriou L, Python S, Summerfield A, Ruggli N. Classical swine fever virus N(pro) limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7. J Virol 2011; 85:8002-11.
63. Arnold MM, Patton JT. Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J Virol 2011; 85:1970-9.
64. Leung LW, Park MS, Martinez O, Valmas C, Lopez CB, Basler CF. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol Cell Biol 2011; 89:792-802.
65. Verbruggen P, Ruf M, Blakqori G, Overby AK, Heidemann M, Eick D, Weber F. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem 2011; 286:3681-92.
66. Leang RS, Wu TT, Hwang S, Liang LT, Tong L, Truong JT, Sun R. The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection. PLoS Pathog 2011; 7:e1002292.
67. Zhang Q, Gong R, Qu J et al. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J Virol 2012; 86:1544-54.
68. Ambrose RL, Mackenzie JM. West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion. J Virol 2011; 85:2723-32.
69. Liu J, HuangFu WC, Kumar KG et al. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 2009; 5:72-83.
70. Pitha PM, Kunzi MS. Type I interferon: the ever unfolding story. Curr Top Microbiol Immunol 2007; 316:41-70.
71. Ren J, Kolli D, Liu T, Xu R, Garofalo RP, Casola A, Bao X. Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS ONE 2011; 6:e24496.
72. Gauzzi MC, Barbieri G, Richter MF, Uze G, Ling L, Fellous M, Pellegrini S. The amino-terminal region of Tyk2 sustains the level of interferon α receptor 1, a component of the interferon α/β receptor. Proc Natl Acad Sci U S A 1997; 94:11839-44.
73. Hong S, Mehta KP, Laimins LA. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol 2011; 85:9486-94.
74. Schomacker H, Hebner RM, Boonyaratanakornkit J, Surman S, Amaro-Carambot E, Collins PL, Schmidt AC. The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome. PLoS ONE 2012; 7:e28382.
75. Jie Z, Dinwiddie DL, Senft AP, Harrod KS. Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus. Virus Res 2011; 156:127-33.
76. Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004; 30:893-900.
77. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006; 344:328-39.
78. Mutocheluh M, Hindle L, Areste C et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. J Gen Virol 2011; 92(Pt 10):2394-8.
79. Kadeppagari RK, Sanchez RL, Foster TP. HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms. Virus Res 2012;167:273-84.
80. Li SW, Lai CC, Ping JF, Tsai FJ, Wan L, Lin YJ, Kung SH, Lin CW. Severe acute respiratory syndrome coronavirus papain-like protease suppressed α interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways. J Gen Virol 2011;92(Pt 5):1127-40.
81. Sohn SY, Hearing P. Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J Virol 2011; 85:7555-62.
82. Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, Torchia J, Mymryk JS. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 2012; 11:597-606.
83. Marazzi I, Ho JS, Kim J et al. Suppression of the antiviral response by an influenza histone mimic. Nature 2012; 483:428-33.
84. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates interferon stimulatory gene IFITM1 by up-regulating miR-130a. J Virol 2012;86:10221-5.
85. Kim YE, Lee JH, Kim ET et al. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol 2011; 85:11928-37.
86. Liu SY, Sanchez DJ, Cheng G. New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 2011; 23:57-64.
87. Tan JC, Avdic S, Cao JZ, Mocarski ES, White KL, Abendroth A, Slobedman B. Inhibition of 2', 5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol 2011; 85:5696-700.
88. Andersson MG, Haasnoot PC, Xu N, Berenjian S, Berkhout B, Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 2005; 79:9556-65.
89. Meng H, Deo S, Xiong S, Dzananovic E, Donald LJ, van Dijk CW, McKenna SA. Regulation of the interferon-inducible 2'-5'-oligoadenylate synthetases by adenovirus VA(I) RNA. J Mol Biol 2012; 422:635-49.
90. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 2012; 11:607-16.
91. Tu YC, Yu CY, Liang JJ, Lin E, Liao CL, Lin YL. Blocking dsRNA-activated protein kinase PKR by Japanese Encephalitis Virus nonstructural protein 2A. J Virol 2012; 86:10347-58.
92. White JP, Reineke LC, Lloyd RE. Poliovirus switches to an eIF2-independent mode of translation during infection. J Virol 2011; 85:8884-93.
93. Jancovich JK, Jacobs BL. Innate immune evasion mediated by the Ambystoma tigrinum virus eukaryotic translation initiation factor 2α homologue. J Virol 2011; 85:5061-9.
94. Ku CC, Che XB, Reichelt M et al. Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication. Immunol Cell Biol 2011; 89:173-82.
95. Zhu H, Cong JP, Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci U S A 1997; 94:13985-90.
96. Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011; 332:1093-7.
97. Frias AH, Jones RM, Fifadara NH, Vijay-Kumar M, Gewirtz AT. Rotavirus-induced IFN-β promotes anti-viral signaling and apoptosis that modulate viral replication in intestinal epithelial cells. Innate Immun 2012; 18:294-306.
98. Strebovsky J, Walker P, Dalpke AH. Suppressor of cytokine signaling proteins as regulators of innate immune signaling. Front Biosci 2012; 17:1627-39.
99. Charoenthongtrakul S, Zhou Q, Shembade N, Harhaj NS, Harhaj EW. Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-κB-dependent induction of SOCS1. J Virol 2011; 85:6955-62.
100. Funaoka Y, Sakamoto N, Suda G et al. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J Virol 2011; 85:5986-94.